Eli Lilly and Co. and Acrux received approval from the FDA for Axiron (testosterone) topical solution CIII for replacement therapy in men for conditions associated with a deficiency or absence of testosterone. Study results show that Axiron can restore blood concentration of testosterone within the normal range in most men. Axiron is the first testosterone topical solution approved for application via an underarm applicator. Other forms include: oral tablets, subcutaneous, transdermal patches...